Endoscopic Innovation Treatment Strategy in Hepatocellular Carcinoma (HCC) Patients Before Immunotherapy: A Case Series Study in Unselected Patients. [PDF]
ABSTRACT Hepatocellular carcinoma remains a major problem in Asia as well as globally. Most patients present at the late stage of the disease. Currently, several types of immunotherapy (IT) have been studied for its efficacy in treating hepatocellular carcinoma, such as atezolizumab and bevacizumab, which work as inhibitors in checkpoints and ...
Syofyan SD +8 more
europepmc +2 more sources
Analysis of the treatment outcome of duodenal varices: A retrospective case series of 15 patients from a single institution. [PDF]
Abstract Background & aims Duodenal varices (DVs) are a rare type of ectopic varices occurring in portal hypertension, for which no standardized treatment strategy has been established. This retrospective study analyzed the outcomes of DV treatments in 15 patients. Material and methods All enrolled patients with DVs were treated at a single institution
Mitamura Y +23 more
europepmc +2 more sources
The role of partial splenic artery embolization in the management of refractory esophageal variceal bleeding due to portal vein thrombosis [PDF]
Background Gastro-esophageal variceal hemorrhage (GEVH) is one of the major causes of life-threatening gastrointestinal bleeding in children. Medical, endoscopic, angiographic, and surgical interventions can be utilized in treatment. In this case report,
Büşra Tetik Dinçer +4 more
doaj +2 more sources
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. [PDF]
BACKGROUND: Nonselective beta-adrenergic blockers decrease portal pressure and prevent variceal hemorrhage. Their effectiveness in preventing varices is unknown.
Bosch, J +12 more
core +1 more source
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis [PDF]
Background. The knowledge of natural history of patients with portal hypertension (PH) not due to cirrhosis is less well known than that of cirrhotic patients. Aim.
Aprile, Francesca +7 more
core +1 more source
Significance of Non-Invasive Markers as Predictor of Esophageal Varices in Liver Cirrhosis
Introduction: Upper gastro-intestinal endoscopy remains the gold standard for screening for esophageal varices but it has its own limitations. It is an invasive, expensive and uncomfortable procedure and needs clinical expertise.
Dipendra Khadka +7 more
doaj +1 more source
Background Esophageal varices (EV) is the most common apprehensive complication of portal hypertension in patients with cirrhotic liver. Guidelines recommend Upper gastro-intestinal endoscopic screening for EV in patients with newly diagnosed chronic ...
Mohamed Alaa ELdin Nouh +3 more
doaj +1 more source
A Fibreoptic Endoscopic Study of Upper Gastrointestinal Bleeding at Bugando Medical Centre in Northwestern Tanzania: a Retrospective Review of 240 Cases. [PDF]
Upper gastrointestinal (GI) bleeding is recognized as a common and potentially life-threatening abdominal emergency that needs a prompt assessment and aggressive emergency treatment.
A Elghuel +45 more
core +2 more sources
Portosystemic collateral vessels in liver cirrhosis: a three-dimensional MDCT pictorial review [PDF]
PURPOSE: Portosystemic collateral vessels (PSCV) are a consequence of the portal hypertension that occurs in chronic liver diseases. Their prognosis is strongly marked by the risk of digestive hemorrhage and hepatic encephalopathy. MATERIALS AND METHODS:
A. Bouvier +7 more
core +4 more sources
Prevalence and Outcome of Bleeding Gastro-esophageal Varices in Medical Intensive Care Unit at Zagazig University Hospitals, Egypt [PDF]
الخلفية وهدف الدراسة:تمزق الدوالي المعدية المريئية (GEV) هو السبب الأكثر حدة وتكرارًا لنزيف الجهاز الهضمي لدى مرضى تليف الكبد، مما يؤدي إلى الوفاة في 5 ٪ إلى 8 ٪ من المرضى خلال الـ 48 ساعة الأولى. في الآونة الأخيرة، انخفض معدل الوفيات لمدة 6 أسابيع من 34 ٪ إلى 20 ٪ بسبب تطوير استراتيجيات علاج فعالة.
Abdulla Abdel-Aziz, Monkez Yousif
openaire +1 more source

